"Cardio-screening" panel
The "Cardio-Screening" Panel is a comprehensive laboratory assessment of a patient’s cardiometabolic profile aimed at the early detection of factors leading to myocardial infarction, stroke, and atherosclerosis.
This is not just a set of laboratory tests, but a tool for clinical decision-making and risk management.
The panel combines key biomarkers reflecting lipid metabolism, inflammatory processes, vascular wall condition, and metabolic disorders.
Unlike basic studies, this profile not only identifies current abnormalities but also helps predict the likelihood of future cardiovascular events.
From a practical perspective, the panel addresses several tasks:
- stratification of individual cardiovascular risk;
- detection of hidden disorders that have not yet manifested clinically;
- determination of preventive strategies (lifestyle changes, medication correction);
- monitoring the effectiveness of therapy (including statins and other medications);
- development of a personalized patient management strategy.
The panel is especially relevant for patients with risk factors such as arterial hypertension, diabetes mellitus, excess body weight, smoking, sedentary lifestyle, chronic stress, and a family history of cardiovascular diseases.
The key advantage is the ability to "catch" the risk before it develops into an actual event. In clinical practice, this means a transition from reactive medicine to proactive medicine: not treating consequences, but managing causes.
By scanning the QR code, you can:
- calculate an individual 10-year cardiovascular risk;
- visualize the risk level (low, moderate, high, very high);
- obtain target lipid level references;
- understand how far current indicators deviate from a safe profile.